title: Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
authors.affiliation: Hamilton Civics Hospitals Research Centre, ON, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: T E
authors.initials: TE
authors.lastname: Warkentin
authors.forename: S G
authors.initials: SG
authors.lastname: Shaughnessy
authors.forename: S S
authors.initials: SS
authors.lastname: Anand
authors.forename: J L
authors.initials: JL
authors.lastname: Halperin
authors.forename: R
authors.initials: R
authors.lastname: Raschke
authors.forename: C
authors.initials: C
authors.lastname: Granger
authors.forename: E M
authors.initials: EM
authors.lastname: Ohman
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
mesh_terms: D000789:Angina, Unstable / Q000188:drug therapy; D000925:Anticoagulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D006493:Heparin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D020246:Venous Thrombosis / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin